Adipocytokines and Polycystic Ovary Syndrome (PCOS)

NCT00975832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2009-09-11

No results posted yet for this study

Summary

Inflammation may play a role in the development of polycystic ovary syndrome (PCOS). In this study, the investigators investigated the expression of different mediators of inflammation in fatty tissue and in blood in women with and without PCOS.

Conditions

  • Polycystic Ovary Syndrome

Sponsors & Collaborators

  • Statens Serum Institut

    collaborator OTHER
  • Aarhus University Hospital

    collaborator OTHER
  • Hvidovre University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00975832 on ClinicalTrials.gov